Ingrid Chemin – Page 19

14/05/2020 : Combined General Meeting of May 14, 2020 Second meeting scheduled for June 25, 2020 Update on Covid-19 activities

Post author:Ingrid Chemin
Post published:14 May 2020
Post category:Press Releases

Croissy-Beaubourg, May 14, 2020, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), which specializes in in vitro diagnostics and theranostics, today announces that its Annual General Meeting convened on May 14, 2020 could not validly…

Presentation Combined General Meeting of Shareholders – May, 14th 2020

Post author:Ingrid Chemin
Post published:14 May 2020
Post category:Financial presentations Non classé

The Company is not in a position to make available the presentation of the Shareholders' Meeting scheduled for today at 2:00 p.m. and will communicate this at a later date.

22/04/2020 : Theradiag committed to fight Covid-19 and reviews the potential impact for 2020

Post author:Ingrid Chemin
Post published:22 April 2020
Post category:Press Releases

Croissy-Beaubourg, April 22, 2020, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER) specializes in in vitro diagnostics and theranostics. Strategic positioning and decisions on Covid-19 serological testsFollowing the approval of Theradiag’s Board of Directors, at a…